24 June 2021
US launch of Accrufer® confirmed for July 1, 2021
Shield Therapeutics plc, confirms that, in line with prior guidance, it will launch Accrufer® in the US on July 1, 2021.
Launch stocks of Accrufer® are currently being distributed through the wholesaler channels and will be available to doctors and other prescribers in all parts of the US by July 1, 2021. A sales force including 30 sales representatives has been recruited and trained and will be starting to contact key prescribers during next week.
For further details click here.